First Wave BioPharma, Inc. also files under GRDX, ENTO, AZRX; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Sawyer Jason David | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Mar 31, 2026 | Sawyer Jason David | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Jan 1, 2026 | Uppal Manpreet | Director | Grant(A) | 40K | — | $0 |
| Jan 1, 2026 | Borkowski Edward | Director | Grant(A) | 40K | — | $0 |
| Jan 1, 2026 | Syage Jack | Director | Grant(A) | 40K | — | $0 |
| Jan 1, 2026 | Pursglove Geordan Garrett | Director | Grant(A) | 40K | — | $0 |
| Dec 22, 2025 | Sawyer Jason David | Chief Executive Officer, Director | Grant(A) | 40K | — | $0 |
| Dec 22, 2025 | Skowron Anna | Interim CFO | Grant(A) | 65K | — | $0 |
| Jan 6, 2025 | Romano Sarah | Chief Financial Officer | Sell(S) | 727 | $0.64 | $465 |
| Oct 9, 2024 | Romano Sarah | Chief Financial Officer | Sell(S) | 476 | $0.45 | $214 |
| Jul 2, 2024 | Romano Sarah | Chief Financial Officer | Sell(S) | 621 | $1.07 | $664 |
| Jul 2, 2024 | Sapirstein James | Chairman and CEO, Director | Sell(S) | 1K | $1.07 | $1K |
| Jun 11, 2024 | Khosla Chaitan PHD | Director | Grant(A) | 25K | — | $0 |
| Apr 1, 2024 | Sapirstein James | Chairman and CEO, Director | Sell(S) | 174 | $4.23 | $736 |
| Apr 1, 2024 | Romano Sarah | Chief Financial Officer | Sell(S) | 75 | $4.23 | $317 |
| Mar 15, 2024 | Romano Sarah | Chief Financial Officer | Sell(S) | 1K | $4.96 | $6K |
| Mar 15, 2024 | Sapirstein James | Chairman and CEO, Director | Sell(S) | 2K | $4.96 | $9K |
| Mar 13, 2024 | Khosla Chaitan PHD | Director | Grant(A) | 440 | — | — |
| Mar 13, 2024 | Khosla Chaitan PHD | Director | Grant(A) | 141 | — | — |
| Mar 13, 2024 | Khosla Chaitan PHD | Director | Grant(A) | 53K | — | — |
| Mar 13, 2024 | Syage Jack | President & COO, Director | Grant(A) | 15K | — | — |
| Mar 13, 2024 | Syage Jack | President & COO, Director | Grant(A) | 5K | — | — |
| Jan 12, 2024 | Romano Sarah | Chief Financial Officer | Sell(S) | 98 | $4.20 | $412 |
| Jan 12, 2024 | Sapirstein James | Chairman, President and CEO, Director | Sell(S) | 166 | $4.20 | $697 |
| Jan 2, 2024 | Coelho Mary Theresa | Director | Grant(A) | 20K | — | $0 |
| Jan 2, 2024 | Romano Sarah | Chief Financial Officer | Grant(A) | 7K | — | $0 |
| Jan 2, 2024 | Sapirstein James | Chairman, President and CEO, Director | Grant(A) | 20K | — | $0 |
| Jan 2, 2024 | Borkowski Edward | Director | Grant(A) | 20K | — | $0 |
| Jan 2, 2024 | Riddell Alastair | Director | Grant(A) | 20K | — | $0 |
| Jan 2, 2024 | Casamento Charles J | Director | Grant(A) | 20K | — | $0 |
| Dec 29, 2023 | Sapirstein James | Chairman, President and CEO, Director | Grant(A) | 18K | — | $0 |
| Dec 29, 2023 | Romano Sarah | Chief Financial Officer | Grant(A) | 13K | — | $0 |
| Oct 4, 2023 | Sapirstein James | President and CEO, Director | Sell(S) | 3K | $0.29 | $802 |
| Oct 4, 2023 | Romano Sarah | Chief Financial Officer | Sell(S) | 2K | $0.29 | $486 |
| Sep 15, 2023 | Casamento Charles J | Director | Sell(S) | 10 | $0.43 | $4 |
| Aug 31, 2023 | Casamento Charles J | Director | Sell(S) | 6K | $0.30 | $2K |
| Jul 3, 2023 | Romano Sarah | Chief Financial Officer | Sell(S) | 2K | $1.54 | $3K |
| Jul 3, 2023 | Sapirstein James | President and CEO, Director | Sell(S) | 3K | $1.54 | $5K |
| Apr 3, 2023 | Sapirstein James | President and CEO, Director | Sell(S) | 3K | $2.50 | $8K |
| Apr 3, 2023 | Romano Sarah | Chief Financial Officer | Sell(S) | 2K | $2.50 | $5K |
| Jan 3, 2023 | Casamento Charles J | Director | Grant(A) | 85K | — | $0 |
| Jan 3, 2023 | Riddell Alastair | Director | Grant(A) | 85K | — | $0 |
| Jan 3, 2023 | Hoffman David Andrew | Director | Grant(A) | 85K | — | $0 |
| Jan 3, 2023 | Borkowski Edward | Director | Grant(A) | 85K | — | $0 |
| Jan 3, 2023 | Sapirstein James | President and CEO, Director | Grant(A) | 300K | — | $0 |
| Jan 3, 2023 | Romano Sarah | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jan 3, 2023 | Coelho Mary Theresa | Director | Grant(A) | 85K | — | $0 |
| Mar 1, 2022 | Romano Sarah | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jan 3, 2022 | Pennington James | CHIEF MEDICAL OFFICER | Grant(A) | 8K | — | $0 |
| Jan 3, 2022 | Schramm Vern Lee | Director | Grant(A) | 34K | — | $0 |
| Jan 3, 2022 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Grant(A) | 10K | — | $0 |
| Jan 3, 2022 | Oakes Gregory | Director | Grant(A) | 34K | — | $0 |
| Jan 3, 2022 | Borkowski Edward | Director | Grant(A) | 34K | — | $0 |
| Jan 3, 2022 | Sapirstein James | PRES, CEO & CHAIRMAN OF BOARD, Director | Grant(A) | 150K | — | $0 |
| Jan 3, 2022 | Coelho Mary Theresa | Director | Grant(A) | 34K | — | $0 |
| Jan 3, 2022 | Riddell Alastair | Director | Grant(A) | 34K | — | $0 |
| Jan 3, 2022 | Casamento Charles J | Director | Grant(A) | 34K | — | $0 |
| Sep 9, 2021 | Coelho Mary Theresa | Director | Grant(A) | 10K | — | $0 |
| Jul 9, 2021 | Pennington James | CHIEF MEDICAL OFFICER | Grant(A) | 100K | — | $0 |
| Jun 30, 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Grant(A) | 250K | — | $0 |
| Jun 30, 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Other(J) | 250K | — | $0 |
| Jun 30, 2021 | Sapirstein James | PRES, CEO & CHAIRMAN OF BOARD, Director | Other(J) | 900K | — | $0 |
| Jun 30, 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Other(J) | 35K | — | $0 |
| Jun 30, 2021 | Sapirstein James | PRES, CEO & CHAIRMAN OF BOARD, Director | Grant(A) | 900K | — | $0 |
| Jun 30, 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Grant(A) | 35K | — | $0 |
| Jan 4, 2021 | Borkowski Edward | Director | Grant(A) | 41K | — | $0 |
| Jan 4, 2021 | Casamento Charles J | Director | Grant(A) | 41K | — | $0 |
| Jan 4, 2021 | Riddell Alastair | Director | Grant(A) | 41K | — | $0 |
| Jan 4, 2021 | Schramm Vern Lee | Director | Grant(A) | 41K | — | $0 |
| Jan 4, 2021 | Oakes Gregory | Director | Grant(A) | 41K | — | $0 |
| Jul 16, 2020 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Grant(A) | 35K | — | $0 |
| Jul 16, 2020 | Sapirstein James | PRESIDENT AND CEO, Director | Grant(A) | 65K | — | — |
| Jul 16, 2020 | Sapirstein James | PRESIDENT AND CEO, Director | Grant(A) | 13 | — | — |
| Jul 16, 2020 | Sapirstein James | PRESIDENT AND CEO, Director | Grant(A) | 1.2M | — | $0 |
| Jul 16, 2020 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Other(J) | 35K | — | $0 |
| Jul 16, 2020 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | Grant(A) | 250K | — | $0 |
| Jul 16, 2020 | Borkowski Edward | Director | Disposed to issuer(D) | 100K | — | — |
| Jul 16, 2020 | Borkowski Edward | Director | Grant(A) | 26K | — | — |
| Jul 16, 2020 | Borkowski Edward | Director | Grant(A) | 46 | — | — |
| Jul 16, 2020 | Borkowski Edward | Director | Grant(A) | 231K | — | — |
| Jul 16, 2020 | Pennington James | CHIEF MEDICAL OFFICER | Grant(A) | 300K | — | $0 |
| Jun 1, 2020 | Borkowski Edward | Director | Grant(A) | 0 | $100,000.00as filed | — |
| Jun 1, 2020 | Borkowski Edward | Director | Disposed to issuer(D) | 0 | $100,000.00as filed | — |
| Apr 13, 2020 | Oakes Gregory | Director | Grant(A) | 60K | — | — |
| Apr 6, 2020 | Riddell Alastair | Director | Grant(A) | 80K | — | — |
| Apr 6, 2020 | Casamento Charles J | Director | Grant(A) | 80K | — | — |
| Apr 6, 2020 | Borkowski Edward | Director | Grant(A) | 80K | — | — |
| Apr 6, 2020 | Schramm Vern Lee | Director | Grant(A) | 80K | — | — |
| Apr 6, 2020 | Spoor Johan M. | Director | Grant(A) | 80K | — | — |
| Mar 19, 2020 | Casamento Charles J | Director | Gift(G) | 9K | — | $0 |
| Mar 19, 2020 | Casamento Charles J | Director | Gift(G) | 9K | — | $0 |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 264 | $4.74 | $1K |
| Mar 11, 2020 | Schramm Vern Lee | Director | Grant(A) | 8K | $1.04 | $9K |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 770 | $4.74 | $4K |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 3K | $3.63 | $10K |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 15K | $0.60 | $9K |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 8K | $1.04 | $9K |
| Mar 11, 2020 | Riddell Alastair | Director | Grant(A) | 3K | $3.99 | $10K |
| Mar 11, 2020 | Schramm Vern Lee | Director | Grant(A) | 15K | $0.60 | $9K |
| Mar 11, 2020 | Casamento Charles J | Director | Grant(A) | 15K | $0.60 | $9K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: First Wave BioPharma, Inc., SEC CIK 0001604191. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under FWBI and shows every filing by that issuer (also filed as GRDX, ENTO, AZRX).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for FWBI